- Epigenetic modification of α-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer
-
Ha YN, Sung HY, Yang SD, Chae YJ, Ju W, Ahn JH
- KMID: 2398554
- Korean J Physiol Pharmacol.
- 2018 Jan;22(1):43-51.
- doi: 10.4196/kjpp.2018.22.1.43
Although cisplatin is one of the most effective antitumor drugs for ovarian cancer, the emergence of chemoresistance to cisplatin in over 80% of initially responsive patients is a major barrier... -
- CITED
-
- Close
- SHARE
-
- Close
